pharmaceutical investing Catalyst Biosciences Announces Korean Ministry of Food and Drug Safety Approves Addition of Sixth Cohort to the Phase 1/2 Trial of CB 2679d/ISU304
pharmaceutical investing Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth
Apex Commences Drilling at Jersey Emerald Property and Announces Amendment to Terms of Lithium Creek Option Agreement
